PET-CT for Vulvar and Vaginal Cancer — What It Stages and Where It Has Limits

Usually yes, though the primary site is not always the most informative part of the scan for these cancers. The tumour at the vulva or vagina will generally show metabolic activity and can help your team understand how much local tissue is involved. The challenge is that the bladder — which sits very close — fills with high-signal tracer during the scan, and tissue immediately adjacent to it can be harder to interpret clearly. MRI is often used alongside PET-CT because it gives better local anatomical detail without the bladder interference.

They answer different questions. MRI gives better detail of the primary tumour — how deeply it has grown, whether it involves nearby structures such as the bladder or rectum. PET-CT gives a whole-body view and is more sensitive for detecting metabolically active lymph nodes and distant spread. Your team may request both for exactly this reason. If you have had only one, ask your oncologist whether the other is also needed for your situation.

No. A PET-CT that shows no abnormal activity means no spread was detected at this level of sensitivity — it does not exclude microscopic disease or involvement of very small nodes. The staging decision is made from the whole picture: your examination findings, your MRI, your PET-CT, and any biopsy results together. Your oncologist will explain what your specific result contributes to that assessment rather than reading it in isolation.

Yes. Menstruation does not affect PET-CT image quality or how the tracer is taken up. You do not need to delay the scan for this reason. If you have concerns about comfort or positioning on the day, let your team know beforehand and they will make adjustments.

No. PET-CT shows areas of high metabolic activity, which is common in cancer but also occurs in inflammation and some benign conditions. It cannot identify the cell type or confirm a diagnosis. That always requires a biopsy and a pathology report. PET-CT is ordered after the diagnosis is established, to determine how far the disease has spread and to guide treatment decisions.

The total appointment is usually around two hours, though most of that time is a waiting period after the tracer injection while it distributes through your body. The scan itself typically takes around twenty to thirty minutes. You will feel the tracer injection but the scan causes no pain or sensation. You will need to lie still during it. If lying flat for an extended period is difficult for you, tell your team before the appointment so they can plan accordingly.